Clinical trial
Tolerance of Long Term Administration of Forlax® 10g in Elderly Ambulatory or Institutionalized Patients Suffering From Chronic Constipation. Single Blind Randomised Lactulose-controlled Study With Individual Expected Benefit.
NCT00276354 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerance of Long Term Administration of Forlax® 10g in Elderly Ambulatory or Institutionalized Patients Suffering From Chronic Constipation. Single Blind Randomised Lactulose-controlled Study With Individual Expected Benefit.
- Lead sponsor
- Ipsen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 1999
- Completion date
- November 20, 2001
- Enrollment
- 246 (actual)
- Sites
- 146
Conditions
As the registry lists them; a condition with its own page is linked.